Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development
Psyence Group Announces a Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development
The Psyence Group Announces its Formal Entry Into Jamaica
Psyence establishes Psyence Jamaica as part of its strategy to develop standardized nutraceutical and pharmaceutical psychedelic products in Jamaica for the treatment of psychological traumas.
Psyence Group Corporate Update
Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”) is pleased to provide the following corporate update on its three clear paths to revenue and value creation namely: Psyence Production, Psyence Therapeutics and Psyence Function.
JV Signed With Pure Extracts
Psyence Group Inc. (CSE: PSYG) (“Psyence”), and Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts”) and are pleased to announce the signing of a Letter of Intent (“LOI”) to form a Joint Venture (the “JV”) to develop superior techniques for the extraction of psilocybin from psychedelic mushrooms, as well as the development of advanced formulations containing psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Partnership with Base Pair Health announced
Psyence Group Announces Partnership With Base Pair Health and [...]
Functional mushroom brand, “GOODMIND”, launched
Psyence Group Launches It's Functional Mushroom Brand, "GoodMind" And [...]
Collaboration with Jamaican retreat provider to conduct observational study
Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin [...]
Psyence presents at Canaccord Genuity Conference
Press Release: Psyence Group Presenting at Canaccord Genuity Conference [...]
First Cultivation of medical psilocybin mushrooms completed
Psyence Group Competes First Cultivation Cycle of Medical Psilocybin [...]
Psyence Group to Commence Trading (CSE : PSYG)
Psyence Group to Commence Trading (CSE: PSYG) on January [...]